A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Nutex Health Inc.
NUTX
$985M
Mkt Cap
$145.87
-5.01%
Nutex Health Inc. (NUTX) has a current P/E ratio of 15.1, compared to its historical median P/E of 3.3. The stock is currently considered Expensive based on its historical valuation range.
Nutex Health Inc. (NUTX) has a 5-year average return on invested capital (ROIC) of 85.6%. This indicates strong capital allocation and a potential competitive advantage.
Nutex Health Inc. (NUTX) has a market capitalization of $1.0B. It is classified as a small-cap stock.
Nutex Health Inc. (NUTX) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.49%.
Based on historical P/E analysis, Nutex Health Inc. (NUTX) appears expensive. The current P/E of 15.1 is 358% above its historical median of 3.3. The estimated fair value CAGR (P/E method) is 37.6%.
Nutex Health Inc. (NUTX) operates in the Services-Business Services, Nec industry, within the Industrials sector.
Nutex Health Inc. (NUTX) reported annual revenue of $875 million in its most recent fiscal year, based on SEC EDGAR filings.
Nutex Health Inc. (“Nutex Health” or the “Company”) is a physician-led, healthcare services and operations company with 26 hospital facilities (as of December 31, 2025) in 12 states (hospital division), and a primary care-centric, risk-bearing population health management division. Our hospital division implements and operates innovative health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (“HOPDs”). The population health management (“PHM”) division owns and operates provider networks such as independent physician associations (“IPAs”). We employ 944 full-time employees, contract more than 280 doctors at our facilities and partner with over 3,600 physicians and specialists within our IPA networks. Our corporate headquarters is based in Houston, Texas. We were incorporated on April 13, 2000 in the state of Delaware.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 880M | 875M | 480M | 248M | 219M | 332M |
| Net Income | 103M | 71M | 52M | -46M | -425M | 133M |
| EPS | $14.75 | $10.48 | $9.69 | $-1,558.50 | $-15,054.00 | $387.13 |
| Free Cash Flow | 269M | 246M | 21M | -8.2M | 36M | 137M |
| ROIC | 98.3% | 114.4% | 93.3% | -44.3% | -269.1% | 179.0% |
| Gross Margin | 47.5% | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% |
| Debt/Equity | 0.13 | 0.24 | 0.57 | 0.90 | 0.60 | 0.97 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | 285M | 276M | 131M | -32M | -407M | 170M |
| Operating Margin | 32.4% | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% |
| ROE | 29.7% | 30.7% | 53.7% | -58.2% | -403.6% | 233.6% |
| Shares Outstanding | 7M | 7M | 5M | 0M | 0M | 0M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 1.1M | 475K | 0 | N/A | 1.4M | N/A | 274M | 332M | 219M | 248M | 480M | 875M | 880M |
| Gross Margin | 56.5% | 98.3% | N/A | N/A | 62.9% | N/A | 57.5% | 54.1% | 7.0% | 14.0% | 40.9% | 50.8% | 47.5% |
| R&D | N/A | N/A | N/A | N/A | 545K | 768K | 557K | 286K | N/A | N/A | N/A | N/A | N/A |
| SG&A | 723K | 533K | 449K | 1.8M | 946K | 3.7M | 4.4M | 5.5M | 20M | 33M | 42M | 52M | 56M |
| EBIT | -723K | -533K | -449K | -5.7M | -840K | -6.9M | 153M | 170M | -407M | -32M | 131M | 276M | 285M |
| Op. Margin | -67.7% | -112.3% | N/A | N/A | -61.5% | N/A | 55.9% | 51.4% | -185.4% | -12.8% | 27.2% | 31.5% | 32.4% |
| Net Income | -684K | 84K | -7.4M | 582K | -950K | -7.1M | 106M | 133M | -425M | -46M | 52M | 71M | 103M |
| Net Margin | -64.0% | 17.7% | N/A | N/A | -69.5% | N/A | 38.7% | 40.0% | -193.7% | -18.5% | 10.9% | 8.1% | 11.7% |
| Non-Recurring | 0 | 6K | 0 | 0 | 0 | 2.3M | 3.4M | 0 | 398M | 1.1M | 3.2M | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/M | -18.4% | -69.4% | -102.2% | -147.7% | N/M | N/A | 179.0% | N/M | -44.3% | 93.3% | 114.4% | 98.3% |
| ROE | -248.1% | 10.8% | 345.0% | -17.0% | 76.2% | -382.9% | N/A | 233.6% | -403.6% | -58.2% | 53.7% | 30.7% | 29.7% |
| ROA | -101.2% | 2.1% | -182.4% | 30.3% | -50.3% | -199.3% | N/A | 67.2% | -102.8% | -11.0% | 9.9% | 9.0% | 10.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 159K | 45K | -274K | 715K | -480K | -4.0M | 87M | 173M | 51M | 1.3M | 23M | 248M | 273M |
| Free Cash Flow | 157K | 43K | -274K | 715K | -480K | -4.1M | 25M | 137M | 36M | -8.2M | 21M | 246M | 269M |
| Owner Earnings | 21K | -288K | -276K | -211K | -639K | -4.6M | 78M | 162M | 37M | -17M | 3.8M | 120M | 250M |
| CapEx | 2K | 2K | 0 | 0 | 0 | 84K | 61M | 37M | 15M | 9.5M | 2.3M | 2.5M | 3.6M |
| Maint. CapEx | 63K | 0 | 0 | 1K | 3K | 87K | 5.9M | 7.7M | 13M | 18M | 19M | 21M | 21M |
| Growth CapEx | 0 | 1K | N/A | N/A | N/A | 0 | 55M | 29M | 1.5M | 0 | 0 | 0 | 0 |
| D&A | 63K | 0 | 0 | 1K | 3K | 87K | 5.9M | 7.7M | 13M | 18M | 19M | 21M | 21M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 755.8% | 10.0% | N/A | 1.3% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.0M | 5.0M |
| Buyback Yield | N/A | N/A | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.5% |
| Stock-Based Comp | 75K | 332K | 2K | 924K | 156K | 450K | 2.6M | 4.0M | 190K | 936K | 394K | 108M | 2.2M |
| Debt Repayment | 49K | 0 | 0 | 200K | 728K | 737K | 1.6M | 1.3M | 1.7M | 3.5M | 4.6M | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | -181K | 732K | 3.2M | 512K | 358K | -424K | 386K | 75M | 23M | 34M | 31M | -106M | -163M |
| Cash & Equiv. | 127K | 122K | 11K | 9K | 119K | 1.1M | 27K | 36M | 34M | 22M | 41M | 186M | 207M |
| Long-Term Debt | -55K | 75K | 50K | 469K | 300K | 0 | 0 | 79M | 23M | 26M | 22M | 29M | 24M |
| Debt/Equity | 12.14 | 0.55 | -0.54 | -0.52 | -0.32 | 0.34 | -0.36 | 0.97 | 0.60 | 0.90 | 0.57 | 0.24 | 0.13 |
| Interest Coverage | -153.3 | -169.4 | -173.9 | -15.5 | -7.7 | -74.8 | 23.8 | 27.5 | -32.6 | -1.9 | 7.8 | 13.3 | 13.5 |
| Equity | -4K | 1.6M | -5.9M | -997K | -1.5M | 1.9M | -1.1M | 115M | 96M | 61M | 132M | 329M | 346M |
| Total Assets | 281K | 7.6M | 511K | 3.3M | 449K | 6.7M | N/A | 395M | 432M | 398M | 655M | 919M | 957M |
| Total Liabilities | 285K | 6.1M | 6.4M | 4.3M | 1.9M | 4.8M | N/A | 203M | 311M | 319M | 467M | 495M | 515M |
| Intangibles | N/A | N/A | N/A | 3.3M | N/A | 1.5M | N/A | 683K | 21M | 21M | 16M | 21M | 21M |
| Retained Earnings | 2.9M | -2.8M | -10M | -9.6M | -5.5M | -13M | -18M | 102M | -363M | -409M | -357M | -286M | -239M |
| Working Capital | -9K | 1.6M | -5.9M | -905K | -739K | -3.4M | -997K | 116M | 43M | 33M | 138M | 381M | 395M |
| Current Assets | 276K | 7.6M | 508K | 55K | 305K | 1.2M | 157K | 154M | 98M | 91M | 292M | 539M | 580M |
| Current Liabilities | 285K | 6.1M | 6.4M | 960K | 1.0M | 4.6M | 1.2M | 38M | 55M | 58M | 154M | 158M | 184M |
| Per Share Data | |||||||||||||
| EPS | -0.69 | 0.05 | -4.38 | 0.69 | -84.64 | -3.23 | 33.07 | 387.13 | -15,054.00 | -1,558.50 | 9.69 | 10.48 | 14.75 |
| Owner EPS | 0.02 | -0.17 | -0.16 | -0.25 | -56.89 | -2.08 | 24.40 | 472.24 | 1,321.40 | -587.87 | 0.70 | 17.74 | 35.90 |
| Book Value | -0.00 | 0.91 | -3.46 | -1.19 | -133.40 | 0.84 | -0.35 | 334.75 | 3,397.32 | 2,091.75 | 24.63 | 48.77 | 49.81 |
| Cash Flow/Share | 0.16 | 0.03 | -0.16 | 0.85 | -42.77 | -1.83 | 27.04 | 506.37 | 1,793.49 | 42.79 | 4.31 | 36.73 | 17.82 |
| Dividends/Share | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 1.0M | 1.7M | 1.7M | 0.8M | 0.0M | 2.2M | 3.2M | 0.3M | 0.0M | 0.0M | 5.4M | 6.8M | 7.0M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 3.3 | N/A | 9.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.2 | N/A | 8.2 | N/A | 3.8 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.3 | N/A | 3.0 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 13.2 | 2.0 | 1.3 | N/A | 2.9 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 11.5 | 1.7 | 0.2 | N/A | 1.2 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.8% | -6.6% | 12.2% | N/A | 26.5% |
| Market Cap | N/A | N/A | 0 | N/A | N/A | N/A | N/A | N/A | 1.3B | 126M | 171M | 0 | 1.0B |
| Avg. Price | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | 594.45 | 94.18 | 17.50 | 0.00 | 145.87 |
| Year-End Price | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | 300.00 | 28.50 | 31.85 | 0.00 | 145.87 |
Nutex Health Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
Nutex Health Inc. trades at 15.1x trailing earnings, compared to its 15-year median P/E of 3.3x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 37.6x vs a median of 4.2x. The company's 5-year average ROIC is 85.6% with a gross margin of 33.4%. Total shareholder yield (buybacks) is 0.5%. At current prices, the estimated annualized return to fair value is -44.3%.
Nutex Health Inc. (NUTX) has a net profit margin of 8.1%. This is a modest margin.
Nutex Health Inc. (NUTX) generated $246 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Nutex Health Inc. (NUTX) has a debt-to-equity ratio of 0.24. This indicates a conservatively financed balance sheet.
Nutex Health Inc. (NUTX) reported earnings per share (EPS) of $10.48 in its most recent fiscal year.
Nutex Health Inc. (NUTX) has a return on equity (ROE) of 30.7%. This indicates the company generates strong returns for shareholders.
Nutex Health Inc. (NUTX) has a 5-year average gross margin of 33.4%. This indicates decent pricing power.
The Ledger Terminal provides 16 years of financial data for Nutex Health Inc. (NUTX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Nutex Health Inc. (NUTX) has a book value per share of $48.77, based on its most recent annual SEC filing.